CoverageForm 410-K10-Q8-K13D13G13F

Silberman David

CIK 0001867998
Chief Financial Officer

Filings

4

Latest Jan 8, 2024

Issuers covered

1

Showing

4 of 4

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Silberman David. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Silberman David has filed

TickerIssuerFilingsLast filed
ORMPOramed Pharmaceuticals Inc.4Jan 8, 2024

All filings

4 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue